Promotional price valid on web orders only. Your contract pricing may differ. Interested in signing up for a dedicated account number?
Learn More
  1. Home
  2. Products
  3. 01001543

CERILLIANT™ Lacosamide-13C, D3 Solution, 1.0 mg/mL in Acetonitrile, Sold by MilliporeSigma™ Supelco™

Catalog No. 01001543 Shop All MilliporeSigma Supelco Products
Change view
Click to view available options
Quantity:
1 mL
1 product options available for selection
Product selection table with 1 available options. Use arrow keys to navigate and Enter or Space to select.
Catalog No. Quantity
01-001-543 1 mL
Use arrow keys to navigate between rows. Press Enter or Space to select a product option. 1 options available.
1 options
Catalog No. 01-001-543 Supplier MilliporeSigma Supelco Supplier No. L0321ML
Add to Cart
Add to Cart

missing translation for 'validMainframeMsg'

Description

Certified reference material

An internal standard suitable for GC/MS or LC/MS applications in lacosamide testing from clinical toxicology and forensic analysis to urine drug testing and isotope dilution methods. Lacosamide is a new antiepileptic drug approved by the FDA in late 2008 for the treatment of partial-onset seizures and diabetic neuropathic pain. The drug is marketed under the trade name Vimpat™.
TRUSTED_SUSTAINABILITY

Specifications

CAS 75-05-8
Linear Formula 13CC12D3H15N2O3
UN Number UN 1648 3 / PGII
Concentration 1.0 mg/mL in acetonitrile
Formula Weight 254.30
Packaging Ampule
Quantity 1 mL
Flash Point 2°C (35.6°F) - closed cup

CERILLIANT is a registered trademark of Cerilliant Corporation

Product Title
Select an issue

By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.